Cybin Inc. (OTCMKTS:CLXPF – Get Free Report) rose 5.1% during trading on Monday . The company traded as high as $0.38 and last traded at $0.37. Approximately 4,788,887 shares were traded during trading, an increase of 768% from the average daily volume of 551,962 shares. The stock had previously closed at $0.35.
Cybin Stock Up 5.1 %
The stock has a market capitalization of $54.68 million and a PE ratio of -1.53. The business’s fifty day moving average is $0.39 and its two-hundred day moving average is $0.41.
Cybin Company Profile
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
See Also
- Five stocks we like better than Cybin
- Airline Stocks – Top Airline Stocks to Buy Now
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- Trading Halts Explained
- 3 Value Stocks You Can Buy Before They Become Big
- Most Volatile Stocks, What Investors Need to Know
- Chinese Stocks Stage Impressive Rebound
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
